ABLC

DRUG2 trials

Sponsors

M.D. Anderson Cancer Center, Medstar Health Research Institute

Conditions

Hematologic MalignanciesInvasive CryptococcosisInvasive Fungal Infections

Phase 3

Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)

CompletedNCT00750737

M.D. Anderson Cancer CenterHematologic Malignancies, Invasive Fungal Infections

Start: 2008-06-30End: 2012-06-30Updated: 2016-09-29

Phase 4

Safety, Efficacy, and Pharmacokinetics of Amphotericin B Lipid Complex

WithdrawnNCT01656382

Medstar Health Research InstituteInvasive Cryptococcosis

Start: 2007-01-31End: 2010-01-31Updated: 2021-02-17